Abstract
Glycosylation is necessary for HIV-1 gp120 to attain a functional conformation, and individual N-linked glycans of gp120 are important, but not essential, for replication of HIV-1 in cell culture. We have constructed a mutant HIV-1 infectious clone lacking a signal for N-linked glycosylation in the V1-loop of HIV-1 gp120. Lack of an N-linked glycan was verified by a mobility enhancement of mutant gp120 in SDS-gel electrophoresis. The mutated virus showed no differences in either gp120 content per infectious unit or infectivity, indicating that the N-linked glycan was neither essential nor affecting viral infectivity in cell culture. We found that the mutated virus lacking an N-linked glycan in the V1-loop of gp120 was more resistant to neutralization by monoclonal antibodies to the V3-loop and neutralization by soluble recombinant CD4 (sCD4). Both viruses were equally well neutralized by ConA and a conformation dependent human antibody IAM-2G12. This suggests that the N-linked glycan in the V1-loop modulates the three-dimensional conformation of gp120, without changing the overall functional integrity of the molecule.
MeSH Terms
Amino Acid Sequence
Antibodies, Monoclonal/immunology
Base Sequence
CD4 Antigens/immunology
Cell Line
Cell Survival
Concanavalin A/immunology
Glycosylation
HIV Antibodies/immunology
HIV Antigens/biosynthesis
HIV Envelope Protein gp120/chemistry,genetics,immunology
HIV-1/chemistry,immunology,physiology
Humans
Molecular Sequence Data
Mutagenesis
Neutralization Tests
Peptide Fragments/chemistry,genetics,immunology
Polysaccharides/chemistry
Protein Conformation
Recombinant Proteins/immunology
Chemicals
Antibodies, Monoclonal
CD4 Antigens
HIV Antibodies
HIV Antigens
HIV Envelope Protein gp120
HIV envelope protein gp120 (135-148)
HIV envelope protein gp120 (305-321)
Peptide Fragments
Polysaccharides
Recombinant Proteins
recombinant soluble CD4
Concanavalin A
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Gram G J
Laboratory for Infectious Diseases, Hvidovre Hospital, Denmark.
Hemming A
Bolmstedt A
Jansson B
Olofsson S
Akerblom L
Nielsen J O
Hansen J E
References (20)
20 references, click to expand
-
Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.
J Virol. 1994 Apr;68(4):2253-9
PMID: 8139010
-
Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.
Virology. 1983 Aug;129(1):51-64
PMID: 6412453
-
Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop.
J Virol. 1993 Aug;67(8):4785-96
PMID: 7687303
-
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.
Science. 1985 Aug 9;229(4713):563-6
PMID: 2992081
-
Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.
J Virol. 1991 Sep;65(9):4777-85
PMID: 1870202
-
Detection of HIV antigens in eluates from whole blood collected on filterpaper.
Lancet. 1987 Mar 7;1(8532):566-7
PMID: 2881117
-
Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1.
J Virol. 1990 Jun;64(6):2841-8
PMID: 2335819
-
Carbohydrate determinant NeuAc-Gal beta (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120.
J Gen Virol. 1992 Dec;73 ( Pt 12):3099-105
PMID: 1281869
-
Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.
Science. 1992 Jul 24;257(5069):535-7
PMID: 1636088
-
Neutralization of HIV-1: a paradox of humoral proportions.
FASEB J. 1991 Jul;5(10):2437-55
PMID: 1712328
-
Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.
AIDS. 1990 Oct;4(10):953-60
PMID: 1702001
-
An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization.
Virology. 1994 Mar;199(2):431-8
PMID: 8122371
-
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
J Biol Chem. 1990 Jun 25;265(18):10373-82
PMID: 2355006
-
A strategy simplifying site-directed mutagenesis in the CD4-binding region of HIV gp 120.
Arch Virol. 1989;107(3-4):301-5
PMID: 2554859
-
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
Cell. 1987 Sep 11;50(6):975-85
PMID: 2441877
-
Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region.
EMBO J. 1992 Feb;11(2):585-91
PMID: 1537337
-
Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus.
J Virol. 1991 Dec;65(12):6461-7
PMID: 1719230
-
Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1.
Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2213-7
PMID: 1549584
-
An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1.
AIDS. 1989 Mar;3(3):155-63
PMID: 2540772
-
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.
Science. 1984 May 4;224(4648):497-500
PMID: 6200935